内镜下自膨式金属支架与手术旁路治疗不可手术胰腺癌相关恶性胆道梗阻的疗效:倾向性评分匹配分析
该回顾性研究纳入2008至2016年因胰腺癌所致恶性胆道梗阻接受内镜下自膨式金属支架(SEMS)或手术旁路(SB)的连续患者,经1:1倾向性评分匹配后每组各30例。SB组住院时间显著更长,SEMS组再入院率和再干预率更高,但SB组总治疗费用显著更高。结论认为SB虽然创伤更大且费用更高,但能持久解除胆道梗阻;SEMS操作风险小、再干预率低,对预期寿命有限的虚弱患者是重要考虑。
要点
- 匹配后SB组住院时间显著长于SEMS组(13 vs. 5天,P<0.001)。
- SEMS组再入院率(36.7 vs. 3.3%,P=0.004)和再干预率(36.7 vs. 10%,P=0.033)均显著高于SB组。
- SB组总治疗费用显著高于SEMS组(13,307 vs. 7113 USD,P=0.035)。
核心结论
- 手术旁路虽创伤更大且费用更高,但能持久解除胆道梗阻。
- 内镜下自膨式金属支架操作风险小、再干预率低,适合预期寿命有限的虚弱患者。
研究设计与样本
- 回顾性分析2008至2016年连续因胰腺癌相关恶性胆道梗阻接受内镜下自膨式金属支架或手术旁路的患者。
- 排除非胰腺癌诊断及Whipple术前置入支架进行术前引流的患者。
- 采用倾向性评分1:1匹配后每组各30例进行分析。
主要发现
- 共98例患者,中位年龄68.5岁,52%有转移性疾病,中位生存期6个月。
- 手术旁路组住院时间显著更长(13 vs. 5天,P<0.001),早期治疗相关事件发生率有更高趋势(24.1 vs. 6.7%,P=0.113)。
- 手术旁路组无患者发生复发性胆道梗阻。
- 内镜支架组再入院率(36.7 vs. 3.3%,P=0.004)和再干预率(36.7 vs. 10%,P=0.033)均显著更高。
- 内镜支架组与手术旁路组3、6、9个月再干预率分别为24.9%、29.4%、45.7%与11.2%、11.2%、11.2%(P=0.03)。
关键数值与推荐
- 手术旁路组住院时间13天,内镜支架组5天(P<0.001)。
- 手术旁路组早期治疗相关事件发生率24.1%,内镜支架组6.7%(P=0.113)。
- 内镜支架组再入院率36.7%,手术旁路组3.3%(P=0.004)。
- 内镜支架组再干预率36.7%,手术旁路组10%(P=0.033)。
- 计入所有后续再入院后,两组住院时间无显著差异(7.5 vs. 14天,P=0.359);手术旁路组总治疗费用显著高于内镜支架组(13,307 vs. 7113 USD,P=0.035)。
临床怎么用
- 对预期寿命有限、虚弱且希望减少再干预的胰腺癌相关恶性胆道梗阻患者,内镜下自膨式金属支架是合理选择。
- 对预期生存较长、能耐受手术且希望持久解除梗阻的患者,手术旁路可避免反复再干预。
- 决策时需综合评估患者体能状态、预期寿命、再干预风险及治疗费用。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 倾向性评分匹配后样本量较小(每组30例)。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: We explored the difference in treatment efficacy of endoscopic self-expendable metal stent (SEMS) and surgical bypass (SB) in the management of malignant biliary obstruction (MBO) secondary to pancreatic cancer. METHOD: A retrospective analysis was conducted using consecutive patients who were admitted from 2008 to 2016 receiving either endoscopic SEMS or SB. Diagnosis other than pancreatic cancer and SEMS placement as a pre-operative drainage before Whipple's operation was excluded. Propensity score (PS) matching was performed to eliminate the confounding effect of heterogeneity between patients from two treatment groups. The rate of early, late treatment-related events, readmission and re-intervention, the duration of hospitalization, and the cost of treatment were compared. RESULTS: There were 98 patients undergoing endoscopic SEMS or SB in the study period. The median age was 68.5 years and 52% of the patients had metastatic disease with median survival of 6 months. After 1:1 PS matching, 30 patients from each group were analyzed. The hospital stay was significantly longer in the SB group (13 vs. 5 days, P < 0.001) with a trend of higher rate of early treatment-related events (24.1 vs. 6.7%, P = 0.113). None of the patients in SB group developed recurrent biliary obstruction. Higher readmission rate (36.7 vs. 3.3%, P = 0.004) and re-intervention rate (36.7 vs. 10%, P = 0.033) were found in the SEMS group. The 3-, 6-, and 9-month re-intervention rates for endoscopic SEMS and SB group were 24.9, 29.4, 45.7, and 11.2, 11.2, and 11.2%, respectively (P = 0.03). When all subsequent readmissions were taken into account, there was no significant difference in hospital stay in both groups (7.5 vs. 14 days, P = 0.359); however, the total cost of treatment in SB group was significantly higher than that in the SEMS group (13,307 vs. 7113 USD, P = 0.035). CONCLUSION: Despite being more invasive and expensive, surgical bypass provides durable relief of biliary obstruction. Endoscopic SEMS is associated with minimal procedural risks and low re-intervention rate, which are important considerations for frail patients with limited life expectancy.
引用
- Ma KW, Chan ACY, She WH, et al. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis. Surg Endosc. 2017. PMID: 28779260. doi:10.1007/s00464-017-5774-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。